Bioproduction and genetically engineered cell lines for a variety of applications, including cGMP production of biotherapeutics and drug discovery.
Oxford Genetics has expertise in generating stable, recombinant, cell lines expressing both proteins and viruses. This has included expressing a wide range of challenging proteins and developing the first method to constitutively express highly toxic proteins such as the viral glycoprotein VSV-G.
Recent advances in genetic engineering technologies have facilitated the systematic genetic manipulation of mammalian cells for a range of applications. At Oxford Genetics we work closely with our clients to develop a strategy that best addresses their project needs and use technologies to create a custom cell line to meet their specifications.